Alimera Sciences
(NASDAQ) ALIM
Alimera Sciences Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$99.68M
Net Income (TTM)
$14.70M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ALIM News
2 Stocks Stopping the Presses
Alimera Annihilates Its Doubters
5 of Last Week's Biggest Losers
These 2 Biotechs Got Crushed
Hidden Stocks for High Returns
ALIM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alimera Sciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
159
CEO
Richard S. Eiswirth, Jr., CPA
Website
www.alimerasciences.comHeadquarters
Alpharetta, GA 30005, US
ALIM Financials
Key Financial Metrics (TTM)
Gross Margin
76%
Operating Margin
-2%
Net Income Margin
-25%
Return on Equity
-2%
Return on Capital
-1%
Return on Assets
-13%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
-6.25%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$61.17M
Operating Income
$1.93M
EBITDA
$1.11M
Operating Cash Flow
$14.26M
Capital Expenditure
$75.53M
Free Cash Flow
$89.79M
Cash & ST Invst.
$12.09M
Total Debt
$67.40M
Alimera Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$27.00M
+54.0%
Gross Profit
$23.17M
+53.3%
Gross Margin
85.81%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
154
N/A
Net Income
$3.31M
+67.0%
EBITDA
$2.89M
+144.9%
Quarterly Fundamentals
Net Cash
$61.30M
-35.1%
Accounts Receivable
$37.08M
+64.1%
Inventory
$3.46M
+227.5%
Long Term Debt
$69.73M
+9.0%
Short Term Debt
$245.00K
+20.7%
Return on Assets
-13.11%
N/A
Return on Invested Capital
-1.47%
N/A
Free Cash Flow
$915.00K
+101.1%
Operating Cash Flow
$1.03M
+117.1%